EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Beamtree Holdings Ltd (BMT) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Beamtree Holdings Ltd A$0.06, price A$0.10, upside -40.0%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · AU · ISIN AU0000170979

BH Thin data Oct 4, 2026

Beamtree Holdings Ltd

BMT · AU

Weakest SetupStrongly overvalued and low quality.

Low debt
Generates free cash flow
Quality 42/100
Mixed Growth (revenue 5y +28.3 %/yr in AUD)
Fair value A$0.0600 · Strongly overvalued (−40.0%)
Loss-making · -62.6% net margin (TTM)
Trails peers (2/11)
Narrow moat 11/100
Thin data
Watch Beamtree Holdings Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$0.6800 A$0.0900 Fair Value A$0.0600 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.

How to read this chart

60‑month range A$0.0900 – A$0.6800 · fair‑value band A$0.0300 – A$0.1000 · the A$0.1000 price screens above the A$0.0600 fair value. Dashed = 300-day average. As of Oct 4, 2026.

Follow Beamtree Holdings in your weekly email

Every Wednesday you see whether Beamtree Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally. It operates through four segments: Diagnostic; Clinical Decision Support; Coding & Data Quality Assurance; and Knowledge Networks.

Show more

Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally. It operates through four segments: Diagnostic; Clinical Decision Support; Coding & Data Quality Assurance; and Knowledge Networks. The company offers Activity BarCoding, and on-premise solution that captures customized data across organizations to support various operations; Ainsoff Deterioration Index, an application that enables acuity monitoring across the whole organization; operational services in health and social services data analytics; and clinical coding, auditing, education and training services. It also provides PICQ, a quality assessment tool for clinically coded data; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; RippleDown Expert that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; and RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors. In addition, the company offers RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; and workforce wellbeing collaborative program. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. The company was founded in 1996 and is headquartered in North Sydney, Australia.

Stock analysis

Beamtree Holdings Ltd (BMT) currently trades at A$0.1000, while our model-based Fair Value estimate is A$0.0600, 40.0% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of A$0.0600 per share, and 0 of the 10 models we run sit above the A$0.1000 price.

Bear case: the Multiples group reads lowest at A$0.0200, and 10 of the 10 models stay below the price. Evidence for this calculation is low.

Scenario range: A$0.0300 (bear) to A$0.1000 (bull), the price of A$0.1000 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Beamtree Holdings Ltd reported revenue of A$29.2M in FY2026 versus A$16.5M in FY2022, a compound +15.2%/yr. Reported net income was −A$18.3M in FY2026.

Key figures

Market cap A$29.1M (≈ $20.2M) · P/S ratio 1.01 · EPS (TTM) A$−0.0600 · Net margin −62.6% · Return on equity −56.0% · Return on assets (EBIT) −10.1% · Operating margin −11.0% · Revenue (TTM) A$29.2M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).

What moves the price

The share trades about 58% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −40%, BMT screens richer than that median.

Fair Value models

Bear A$0.0300 Fair Value A$0.0600 Bull A$0.1000
Price A$0.1000 · Upside -40.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF A$0.0500 A$0.0800 A$0.1700 73
5Y EBITDA Exit A$0.0300 A$0.0400 A$0.0600 73
Growth DCF A$0.0500 A$0.0900 A$0.1700 72
All 10 models by family
DCF Models
FCF DCF A$0.0500 A$0.0800 A$0.1700 73
5Y Revenue Exit A$0.0300 A$0.0600 A$0.1000 68
5Y EBITDA Exit A$0.0300 A$0.0400 A$0.0600 73
10Y Revenue Exit A$0.0400 A$0.0800 A$0.1000 65
10Y EBITDA Exit A$0.0300 A$0.0600 A$0.1000 64
Multiples
EV/EBITDA A$0.0100 A$0.0200 A$0.0200 67
EV/Revenue A$0.0200 A$0.0300 A$0.0500 51
Asset-Based
NCAV (Graham) A$0.0400 A$0.0500 A$0.0800 53
Growth DCF
Growth DCF A$0.0500 A$0.0900 A$0.1700 72
Rev-Margin DCF A$0.0400 A$0.0600 A$0.1200 67

Open the full fair value analysis →

Notify me when BMT reaches fair value

Put BMT on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 42/100

Of which business quality 43 · Market factors (momentum, volatility) 10

Profitability 11
Margins and returns on capital today
Quality Growth 25
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 53
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 21
Calm price path (market factor)
Momentum 5
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 50
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 53/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+2.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.3%
Start year 2021 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−12.3% (2021) → −17.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+22.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Australia: IMF forecast 3.0% a year to 2030, 2.9% from 2016 to 2025) that is about +18.7% a year for the price.

BMT screens overvalued: fair value 40% below the price. Compare with Veeva Systems Inc →

Compare Beamtree Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 117 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 42 · Bottom 25%
Fair Value upside −40.0% · Below median
Profitability
Return on assets −6.6% · Bottom 25%
Net margin (TTM) −62.6% · Bottom 25%
Operating margin (TTM) −11.0% · Bottom 25%
Growth and dividend
Revenue growth 2.1% · Below median
Balance sheet
Debt / equity 0.10× · Above median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 0.86× · Cheapest 25%
P/S (TTM) 0.69× · Cheapest 25%
P/FCF 25.9× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)11 · sector 42
PAST (return on equity)0 · sector 12
HEALTH (low debt)95 · sector 98
DIVIDEND (yield)0 · sector 44

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $278.57 $306.43 +10%
Pro Medicus Limited PME A$161.00 A$84.62 −47%
BrightSpring Health Services, Inc BTSG $56.54 $25.86 −54%
Hinge Health, Inc HNGE $95.57 $51.25 −46%
HealthEquity, Inc HQY $88.44 $97.28 +10%
Waystar Holding WAY $24.70 $27.17 +10%
Doximity, Inc DOCS $27.93 $31.41 +12%
XtalPi Holdings 2228 HK$7.75 HK$1.50 −81%
Inventurus Knowledge Solutions Limited IKS ₹1,779 ₹1,883 +6%
Privia Health Group PRVA $19.62 $5.02 −74%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Beamtree Holdings Ltd · Fair Value
A$0.0600 −40%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Beamtree Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/BMT

Frequently asked questions

Is Beamtree Holdings Ltd (BMT) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of A$0.0600 versus a price of A$0.1000, about −40% upside (overvalued).
What is the fair value of BMT?
Our model-based fair value for Beamtree Holdings Ltd is A$0.0600 (as of Oct 4, 2026), built from audited fundamentals. The current price: A$0.1000.
What is the quality score of BMT?
Beamtree Holdings Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Beamtree Holdings Ltd (BMT)?
Our model-based price target is the fair value of A$0.0600 (as of Oct 4, 2026) from 10 valuation models. Cautious scenario A$0.0300, optimistic scenario A$0.1000. It is a calculation from audited fundamentals, not an analyst target.
What is the Beamtree Holdings Ltd stock forecast for 2026?
Our models put fair value at A$0.0600, about −40% upside versus a price of A$0.1000 (overvalued). Cautious scenario A$0.0300, optimistic scenario A$0.1000. The calculation is refreshed regularly with new filings.
What is the revenue of Beamtree Holdings Ltd (BMT)?
Beamtree Holdings Ltd reported trailing-twelve-month revenue of about A$29.2M (latest available figure, as of Oct 4, 2026).
What growth is priced into Beamtree Holdings Ltd (BMT)?
For today's price to be fair in a discounted-cash-flow model, Beamtree Holdings Ltd would have to grow free cash flow by +22.2 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +28.3 % per year. As of Oct 4, 2026.
What discount rate (WACC) does the fair value of BMT use?
Our models discount Beamtree Holdings Ltd at 10.1 %: a base by market capitalisation (nano), damped by beta 1.25, country premium for Australia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Beamtree Holdings Ltd that is +22.2 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Beamtree Holdings Ltd (BMT) delivered so far?
Over the past 5 years revenue at Beamtree Holdings Ltd grew +28.3 % a year. The price currently implies +22.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Beamtree Holdings Ltd (BMT) growing?
The median revenue growth in the sector is +9.1 % a year. That is the yardstick for the growth priced into Beamtree Holdings Ltd (+22.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Beamtree Holdings Ltd (BMT)?
The free-cash-flow yield on the price is 2.68 %: that much free cash flow Beamtree Holdings Ltd produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Beamtree Holdings Ltd (BMT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Beamtree Holdings Ltd it is A$0.0600 per share (as of Oct 4, 2026), against a price of A$0.1000. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Beamtree Holdings Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, BMT trades above its calculated fair value: price A$0.1000, fair value A$0.0600, a gap of about −40% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BMT?
No. The price is what the market pays today (A$0.1000); the fair value is what the company's own numbers justify (A$0.0600). For Beamtree Holdings Ltd the two are A$0.0400 per share apart. That gap is exactly why we show both numbers side by side.
How much is Beamtree Holdings Ltd worth?
The market values Beamtree Holdings Ltd at about A$29.1M (market capitalisation, as of Oct 4, 2026). Per share that is A$0.1000; our models calculate a fair value of A$0.0600 per share.
What do the bullish and bearish scenarios say about BMT?
Our models span a range for Beamtree Holdings Ltd: cautious scenario A$0.0300, base A$0.0600, optimistic A$0.1000 per share (as of Oct 4, 2026, price A$0.1000). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Beamtree Holdings Ltd (BMT)?
Balance-sheet figures for Beamtree Holdings Ltd (as of Oct 4, 2026): return on equity −56.0%, debt of 0.10 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is BMT from its 52-week high?
Beamtree Holdings Ltd trades at A$0.1000, about 58% below its 52-week high of A$0.2400 and 11% above the low of A$0.0900 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0600 is for.
Which stocks are comparable to Beamtree Holdings Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Beamtree Holdings Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price A$0.1000, calculated fair value A$0.0600 (−40%), Quality Score 42/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BMT calculated?
We run Beamtree Holdings Ltd through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.0600, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Beamtree Holdings Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Beamtree Holdings Ltd (BMT)?
The closing price on Oct 2, 2026 was A$0.1000. Our model-based fair value is A$0.0600, about −40% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Beamtree Holdings Ltd right now?
Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (A$0.0300 to A$0.1000). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Beamtree Holdings Ltd

How large is the market capitalisation of Beamtree Holdings Ltd (BMT)?
The market capitalisation of Beamtree Holdings Ltd is A$29.1M (≈ $20.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Beamtree Holdings Ltd (BMT)?
The price-to-sales ratio of Beamtree Holdings Ltd is 1.01 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Beamtree Holdings Ltd (BMT)?
Earnings per share at Beamtree Holdings Ltd are A$−0.0600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Beamtree Holdings Ltd (BMT)?
The net margin of Beamtree Holdings Ltd is −62.6% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Beamtree Holdings Ltd (BMT)?
The return on equity (ROE) of Beamtree Holdings Ltd is −56.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Beamtree Holdings Ltd (BMT)?
On an EBIT basis the return on assets of Beamtree Holdings Ltd is −10.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Beamtree Holdings Ltd (BMT)?
The operating margin of Beamtree Holdings Ltd is −11.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Beamtree Holdings Ltd (BMT)?
Revenue at Beamtree Holdings Ltd is growing +2.1% versus a year earlier (3y avg +8.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Beamtree Holdings Ltd (BMT) carry?
The net debt of Beamtree Holdings Ltd is A$1.5M (fiscal year 2026, ≈ 2.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Beamtree Holdings Ltd in the live analysis

One click puts Beamtree Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.